Consolidated Statements of Stockholders’ Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021		139,164,693
Beginning balance at Dec. 31, 2021	$ 389,700	$ 1	$ 848,229	$ (1)	$ (458,529)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	87,152		87,152
Exercise of stock options (in shares)		1,569,999
Exercise of stock options	7,004		7,004
Vesting of restricted stock units (in shares)		3,408,672
Vesting of restricted stock units	307	$ 0	307
Reclassification of stock appreciation rights	62		62
Issuances of common stock under employee stock purchase plan (in shares)		870,422
Issuance of common stock under employee stock purchase plan	9,192		9,192
Other comprehensive income (loss)	(232)			(232)
Net loss	(153,875)				(153,875)
Ending balance (in shares) at Dec. 31, 2022		145,013,786
Ending balance at Dec. 31, 2022	339,310	$ 1	951,946	(233)	(612,404)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	104,772		104,772
Exercise of stock options (in shares)		5,477,153
Exercise of stock options	17,996		17,996
Vesting of restricted stock units (in shares)		6,134,641
Vesting of restricted stock units	512	$ 1	511
Issuances of common stock under employee stock purchase plan (in shares)		1,029,344
Issuance of common stock under employee stock purchase plan	8,043		8,043
Shares withheld related to net share settlement of equity awards (in shares)		(488,564)
Shares withheld related to net share settlement of equity awards	(6,760)		(6,760)
Other comprehensive income (loss)	313			313
Net loss	(107,294)				(107,294)
Ending balance (in shares) at Dec. 31, 2023		157,166,360
Ending balance at Dec. 31, 2023	356,892	$ 2	1,076,508	80	(719,698)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	98,408		98,408
Exercise of stock options (in shares)		3,141,652
Exercise of stock options	2,255		2,255
Vesting of restricted stock units (in shares)		6,839,969
Vesting of restricted stock units	202		202
Issuances of common stock under employee stock purchase plan (in shares)		946,694
Issuance of common stock under employee stock purchase plan	7,054		7,054
Shares withheld related to net share settlement of equity awards (in shares)		(4,405,276)
Shares withheld related to net share settlement of equity awards	$ (30,837)		(30,837)
Repurchases of common stock (in shares)	(16,205,119)	(16,205,119)
Repurchases of common stock	$ (151,201)	$ (1)	(151,200)
Other comprehensive income (loss)	(91)			(91)
Net loss	(85,288)				(85,288)
Ending balance (in shares) at Dec. 31, 2024		147,484,280
Ending balance at Dec. 31, 2024	$ 197,394	$ 1	$ 1,002,390	$ (11)	$ (804,986)